Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for IQVIA Holdings Inc. (IQV : NYSE)

• Company Description    IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I Number of Employees: 88,000

• Price / Volume Information    Yesterday's Closing Price: $225.41 Daily Weekly Monthly 20 Day Moving Average: 1,090,300 shares Shares Outstanding: 170.30 (millions) Market Capitalization: $38,387.32 (millions) Beta: 1.36 52 Week High: $234.30 52 Week Low: $134.65 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.22% 0.39% 12 Week 11.04% 9.25% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2400 ELLIS ROAD - DURHAM,NC 27703 USA ph: 919-998-2000 fax: - ir@iqvia.com http://www.iqvia.com

• General Corporate Information    Officers Ari Bousbib - Chief Executive Officer;Chairman;Director Ronald E. Bruehlman - Executive Vice President and Chief Financial Offic Keriann Cherofsky - Senior Vice President; Chief Accounting Officer an Carol J. Burt - Director John P. Connaughton - Director Peer Information IQVIA Holdings Inc. (ABMD) IQVIA Holdings Inc. (DMDS) IQVIA Holdings Inc. (CPWY.) IQVIA Holdings Inc. (EQUR) IQVIA Holdings Inc. (ECIA) IQVIA Holdings Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 46266C105 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/05/26 Share - Related Items Shares Outstanding: 170.30 Most Recent Split Date: (:1) Beta: 1.36 Market Capitalization: $38,387.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $2.62 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $11.73 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 8.38% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/05/26

• Fundamental Ratios P/E Current FY Estimate: 19.21 Trailing 12 Months: 21.41 PEG Ratio: 2.29 Price Ratios Price/Book: 6.10 Price/Cash Flow: 13.57 Price / Sales: 2.41 EPS Growth vs. Year Ago Period: 4.60% vs. Previous Quarter: 7.91% Sales Growth vs. Year Ago Period: 5.24% vs. Previous Quarter: 2.07% ROE 12/31/25 - - 09/30/25 - 30.70 06/30/25 - 30.05 ROA 12/31/25 - - 09/30/25 - 6.64 06/30/25 - 6.77 Current Ratio 12/31/25 - - 09/30/25 - 0.70 06/30/25 - 0.84 Quick Ratio 12/31/25 - - 09/30/25 - 0.70 06/30/25 - 0.84 Operating Margin 12/31/25 - - 09/30/25 - 11.64 06/30/25 - 11.87 Net Margin 12/31/25 - - 09/30/25 - 8.07 06/30/25 - 7.88 Pre-Tax Margin 12/31/25 - - 09/30/25 - 10.05 06/30/25 - 9.80 Book Value 12/31/25 - - 09/30/25 - 36.92 06/30/25 - 34.03 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 2.03 06/30/25 - 2.45 Debt-to-Capital 12/31/25 - - 09/30/25 - 67.05 06/30/25 - 71.02

Powered by Zacks Investment Research ©